Weekly Recap | BioNTech SE -12.43%, halting colorectal cancer vaccine trialWeekly Review·Aug 29 at 05:25 AMBNTX-2.20%
Weekly Recap | BioNTech SE +25.22%, mRNA cancer vaccine breakthrough lifts sectorWeekly Review·Aug 22 at 04:40 AMBNTX-2.20%